These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

757 related articles for article (PubMed ID: 18180250)

  • 1. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
    Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
    Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term follow-up of patients with congenital myasthenic syndrome caused by COLQ mutations.
    Wargon I; Richard P; Kuntzer T; Sternberg D; Nafissi S; Gaudon K; Lebail A; Bauche S; Hantaï D; Fournier E; Eymard B; Stojkovic T
    Neuromuscul Disord; 2012 Apr; 22(4):318-24. PubMed ID: 22088788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic congenital myasthenic syndrome in three patients due to a novel missense mutation (T441A) of the COLQ gene.
    Müller JS; Petrova S; Kiefer R; Stucka R; König C; Baumeister SK; Huebner A; Lochmüller H; Abicht A
    Neuropediatrics; 2004 Jun; 35(3):183-9. PubMed ID: 15248101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel COLQ mutation 950delC in synaptic congenital myasthenic syndrome and symptomatic heterozygous relatives.
    Schreiner F; Hoppenz M; Klaeren R; Reimann J; Woelfle J
    Neuromuscul Disord; 2007 Mar; 17(3):262-5. PubMed ID: 17300939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent COLQ mutation in congenital myasthenic syndrome.
    Guven A; Demirci M; Anlar B
    Pediatr Neurol; 2012 Apr; 46(4):253-6. PubMed ID: 22490774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and molecular analysis of a novel COLQ missense mutation causing congenital myasthenic syndrome in a Syrian family.
    Matlik HN; Milhem RM; Saadeldin IY; Al-Jaibeji HS; Al-Gazali L; Ali BR
    Pediatr Neurol; 2014 Jul; 51(1):165-9. PubMed ID: 24938146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital endplate acetylcholinesterase deficiency responsive to ephedrine.
    Bestue-Cardiel M; Sáenz de Cabezón-Alvarez A; Capablo-Liesa JL; López-Pisón J; Peña-Segura JL; Martin-Martinez J; Engel AG
    Neurology; 2005 Jul; 65(1):144-6. PubMed ID: 16009904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up in patients with congenital myasthenic syndrome due to CHAT mutations.
    Schara U; Christen HJ; Durmus H; Hietala M; Krabetz K; Rodolico C; Schreiber G; Topaloglu H; Talim B; Voss W; Pihko H; Abicht A; Müller JS; Lochmüller H
    Eur J Paediatr Neurol; 2010 Jul; 14(4):326-33. PubMed ID: 19900826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable phenotypes associated with mutations in DOK7.
    Anderson JA; Ng JJ; Bowe C; McDonald C; Richman DP; Wollmann RL; Maselli RA
    Muscle Nerve; 2008 Apr; 37(4):448-56. PubMed ID: 18161030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COLQ-Congenital myasthenic syndrome in an Iranian cohort: the clinical and genetics spectrum.
    Hesami O; Ramezani M; Ghasemi A; Fatehi F; Okhovat AA; Ziaadini B; Kariminejad A; Nafissi S
    Orphanet J Rare Dis; 2024 Mar; 19(1):113. PubMed ID: 38475910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].
    Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D;
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.
    Sigoillot SM; Bourgeois F; Karmouch J; Molgó J; Dobbertin A; Chevalier C; Houlgatte R; Léger J; Legay C
    FASEB J; 2016 Jun; 30(6):2382-99. PubMed ID: 26993635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOK7 congenital myasthenic syndrome.
    Palace J
    Ann N Y Acad Sci; 2012 Dec; 1275():49-53. PubMed ID: 23278577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the C-terminal domain of ColQ in endplate acetylcholinesterase deficiency compromise ColQ-MuSK interaction.
    Nakata T; Ito M; Azuma Y; Otsuka K; Noguchi Y; Komaki H; Okumura A; Shiraishi K; Masuda A; Natsume J; Kojima S; Ohno K
    Hum Mutat; 2013 Jul; 34(7):997-1004. PubMed ID: 23553736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission.
    Müller JS; Mihaylova V; Abicht A; Lochmüller H
    Expert Rev Mol Med; 2007 Aug; 9(22):1-20. PubMed ID: 17686188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ephedrine therapy in eight patients with congenital myasthenic syndrome due to DOK7 mutations.
    Schara U; Barisic N; Deschauer M; Lindberg C; Straub V; Strigl-Pill N; Wendt M; Abicht A; Müller JS; Lochmüller H
    Neuromuscul Disord; 2009 Dec; 19(12):828-32. PubMed ID: 19837590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral vector-mediated [corrected] expression of human collagen Q in cultured cells.
    Ito M; Masuda A; Jinno S; Katagiri T; Krejci E; Ohno K
    Chem Biol Interact; 2008 Sep; 175(1-3):346-8. PubMed ID: 18374322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel truncating RAPSN mutations causing congenital myasthenic syndrome responsive to 3,4-diaminopyridine.
    Banwell BL; Ohno K; Sieb JP; Engel AG
    Neuromuscul Disord; 2004 Mar; 14(3):202-7. PubMed ID: 15036330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three novel COLQ mutations and variation of phenotypic expressivity due to G240X.
    Shapira YA; Sadeh ME; Bergtraum MP; Tsujino A; Ohno K; Shen XM; Brengman J; Edwardson S; Matoth I; Engel AG
    Neurology; 2002 Feb; 58(4):603-9. PubMed ID: 11865139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital myasthenic syndromes: current diagnostic and therapeutic approaches.
    Schara U; Della Marina A; Abicht A
    Neuropediatrics; 2012 Aug; 43(4):184-93. PubMed ID: 22911480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.